Mission Statement

Cholangiocarcinoma-UK, an affiliate of the British Association for Study of Liver Disease (BASL), is a multi-disciplinary Special Interest Group (SIG) of clinicians, scientists and patient advocates whose purpose is to facilitate collaborative research, enhance service development and raise awareness of Cholangiocarcinoma. 

 Aims of Cholangiocarcinoma UK

•        Be the recognised leading authority on Cholangiocarcinoma in the UK

•        Become affiliated to other relevant major national organisations e.g. BASO, BSG

•        Facilitate basic science and clinical research as well as sample collection, including for biomarker development

•        Improve the pathway to collaborative clinical trials and opportunities for research funding

•        Update national guidelines and advise on policy and best practice

•        Optimise and standardise clinical management across the country

•        Monitor epidemiological trends accurately.

Resources

1st meeting - 7 December 2018

Report - Download BASL_BSG report_Summary_Outcomes_CCA-UK Meeting 7 Dec 2018_FINAL.pdf.

Welcome presentation, Shahid Khan, St Mary’s Hospital, London - Download Welcome.pdf

Presentation on the patient/healthcare professional partnership, Helen Morement, AMMF -  Download The patient_healthcare professional partnership.pdf

Presentation on Epidemiology and aetiology: What we don’t know & how can we find out, Shahid Khan, St Mary’s Hospital, London -  Download Epidemiology and aetiology_What we dont know and how we can find out.pdf

Presentation on Ensuring quality: Centres of “excellence/expertise”?, Hassan Malik, Aintree University Hospital Download Ensuring quality_Centres of excellence and expertise.pdf

Presentation on Medical oncology: The unmet needs and how we meet them, John Bridgewater, UCL & Juan Valle, Christie NHS Foundation Trust -  Download Medical oncology_The unmet needs and how we meet them.pdf

Presentation on Clinical oncology: Establishing novel roles in CCA therapy, Maria Hawkins, University of Oxford -  Download Clinical oncology_Establishing novel roles in CCA therapy.pdf

 

Patient representation

The AMMF is represented on the CCA-UK Steering Committee and is the UK’s only cholangiocarcinoma charity - http://ammf.org.uk/

Latest News

The AMMF Cholangiocarcinoma Conference 2019 will be held from 8 – 10 May 2019 at Stansted Airport. For more information and to register, visit http://ammf.org.uk/ammf-conference-2019/. Abstracts deadline: 31st March, 2019.

Follow CCA-UK on Twitter - @ccaukgroup

The Cholangiocarcinoma-UK Committee

Chair Shahid Khan, Imperial College London
Secretary Derek Manas, Freeman Hospital, Newcastle upon Tyne
Basic science  David Bates, University of Nottingham
Clinical oncology  Maria Hawkins, University of Oxford
Endoscopy Steve Pereira, University College London
Hepatology Simon Rushbrook, Norfolk & Norwich Hospital
Medical oncology  John Bridgewater, University College London; Juan Valle, University of Manchester
Patient advocate  Helen Morement, AMMF
Surgery  Hassan Malik, Aintree University Hospital, Liverpool; Nigel Heaton, Kings College London
Trainee representative Geri Keane, Derriford Hospital, Plymouth

Join Basl - BASL Membership covers membership to BASL and all of it's sub-groups: BLNA, BVHG, BLTG, BHPG and HCC-UK. Click here to find out more. BASL 2019 - The BASL Annual Meeting is the highlight of the BASL calendar and the main liver meeting in the UK. Strathclyde University, Glasgow, 18th - 20th September 2019 BASL Events - BASL and the BASL Sub Groups run an exciting and varied calendar of educational events throughout the year, as well as endorsing other not to miss events. Click here to Book Now.